Title of article
Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication Original Research Article
Author/Authors
Martin J. Slater، نويسنده , , Stuart Cockerill، نويسنده , , Robert Baxter، نويسنده , , Robert W. Bonser، نويسنده , , Kam Gohil، نويسنده , , Clare Gowrie، نويسنده , , Edward Robinson، نويسنده , , Edward Littler، نويسنده , , Nigel Parry، نويسنده , , Roger Randall، نويسنده , , Wendy Snowden، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1999
Pages
8
From page
1067
To page
1074
Abstract
In our search for new, safer anti-HCMV agents, we discovered that the natural product Arcyriaflavin A (1a) was a potent inhibitor of HCMV replication in cell culture. A series of analogues (symmetrical indolocarbazoles) was synthesised to investigate structure–activity relationships in this series against a range of herpes viruses (HCMV, VZV, HSV1, and 2). This identified a number of novel, selective and potent inhibitors of HCMV, 12,13-dihydro-2,10-difluoro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-(6H)-dione (1d) being the best example (IC50=40 nM, therapeutic index >1450). Compounds described in this series were generally poor inhibitors of protein kinase C βII, and no correlation was found between the ability to inhibit HCMV and the enzyme PKC.
Keywords
Antiviral , protein kinase C , indolocarbazoles , Human cytomegalovirus , Inhibitors
Journal title
Bioorganic and Medicinal Chemistry
Serial Year
1999
Journal title
Bioorganic and Medicinal Chemistry
Record number
1302309
Link To Document